Functional Validation and Characterization of Cross-Disease Molecular Drivers Linking Alzheimer’s Disease and Type-2 Diabetes Using C. elegans Models Post date October 16, 2026 ← Targeting the Epithelial Myosin Light Chain Kinase to Restore Barrier Integrity and Prevent Food Allergy in Metabolic Dysfunction → Investigating the role of macrophage intrinsic innate immune factors in determining Leishmania donovani infection